Characterization with Atomic Force Microscopy, Topographic, and 3D Raman

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-07-15-2013
Volume 2013 eBook
Issue 1

The authors describe how a combination of imaging techniques can be used to provide topographic and chemical information to characterize a sample.

 

Highly specified drug-delivery systems require specific quality evaluation during the development stage. The authors describe how a combination of imaging techniques can be used to provide topographic and chemical information to characterize a sample three-dimensionally, underneath, and at the surface in a nondestructive manner.

View 

Pharmaceutical Technology’s 2013 Analytical and Bioanalytical Testing ebook

.

 

 

 

 

Articles in this issue
pt-ebook_chrom.jpg
Impurity Profiling Using Convergence Chromatography and Mass Spectrometry
pt_ebooks_nmr.jpg
Multiple Reaction Monitoring–Mass Spectrometry for Biopharmaceutical Analysis
pt_ebooks_lcms.jpg
Simultaneous Quantitative and Qualitative Measurements in Drug-Metabolism Investigations
pt_ebooks_protein.jpg
Identification and Quantification of Trace-Level Protein Impurities
pt_ebooks_hplc.jpg
Ultra-High-Speed Analysis of Ibuprofen Using HPLC
pt_ebooks_microscopy.jpg
Characterization with Atomic Force Microscopy, Topographic, and 3D Raman
Recent Videos
Christian Dunne, director of Global Corporate Business Development at ChargePoint Technology
Behind the Headlines episode 6
Behind the Headlines episode 5
Related Content
Science laboratory test tubes, laboratory equipment | Image Credit: © BillionPhotos.com - © BillionPhotos.com - stock.adobe.com

Orexo and Abera Partner to Develop Nasal Powder Vaccines

Feliza Mirasol
December 20th 2024
Article

The companies will use Orexo’s powder-based drug delivery technology to develop mucosal vaccines in an inhaled formulation.

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Drug Solutions Podcast: Growth and Advancements in Fill/Finish

Felicity Thomas
June 25th 2024
Podcast

In this episode, Hanns-Christian Mahler from ten23 Health chats about the advances in fill/finish.

TOP NEWS on grunge world map | Image Credit: © Sean K - © Sean K - stock.adobe.com

Novo Nordisk to Establish New Production Facility for Rare Disease Therapies in Denmark with DKK 8.5 Billion Investment

Feliza Mirasol
December 17th 2024
Article

Novo Nordisk will use the DKK 8.5 billion (US$1.2 billion) to build a new modular and flexible production facility in Odense, Denmark, that will produce multiple products for rare diseases.

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

Drug Solutions Podcast: Applying Appropriate Analytics to Drug Development

March 26th 2024
Podcast

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Novo Nordisk Gains Manufacturing Sites from Novo Holdings and Novavax while EC Approves Catalent Acquisition

Feliza Mirasol
December 11th 2024
Article

The European Commission has approved Novo Holdings' acquisition of Catalent, which includes the related sale of three manufacturing sites to Novo Nordisk, which is also acquiring the Czech Republic manufacturing site of Novavax for $200 million.

3D printed pills and drugs, future of medicine. 3D Printing Drugs In Pharmacies. Multi-colored, various drugs, pills, capsules. Pharmaceutical medical concept | Image Credit: © irissca - © irissca - stock.adobe.com

Legal and Regulatory Perspectives on 3D Printing: Drug Compounding Applications

Gary Ritchie;Sharon Flank
December 10th 2024
Article

This paper explores the legal and regulatory framework around 3D drug printing, particularly for personalized medicine, considering regulatory compliance, business concerns, and intellectual property rights.